tiprankstipranks
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market
Holding KNSA?
Track your performance easily

Kiniksa Pharmaceuticals (KNSA) Ownership - Who Owns Kiniksa Pharmaceuticals?

431 Followers

Kiniksa Pharmaceuticals (KNSA) Ownership Overview

7.98%9.82%49.84%13.41%18.96%
49.84% Other Institutional Investors
13.41% ETFs
18.96% Public Companies and
Individual Investors
The ownership structure of Kiniksa Pharmaceuticals (KNSA) stock is a mix of institutional, retail, and individual investors. Approximately 73.06% of the company’s stock is owned by Institutional Investors, 7.98% is owned by Insiders, and 18.96% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 21, 2023
xxxxxxxxxxxxx
$178215

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$2099160

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,204,841Institution7.71%66,724,790
3,102,308Institution7.46%64,590,053
2,818,323Institution6.78%58,677,485
2,760,099Insider6.64%57,465,261
1,847,927Institution4.45%38,473,840
798,445Institution1.92%16,623,625
730,943Institution1.76%15,218,233
491,995Institution1.18%10,243,336
429,737Institution1.03%8,947,124
369,825Institution0.89%7,699,757

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
798,445Institution1.92%16,623,625
491,995Institution1.18%10,243,336
429,737Institution1.03%8,947,124
369,825Institution0.89%7,699,757
362,330Institution0.87%7,543,711
189,146Institution0.46%3,938,020
165,976Institution0.40%3,455,620
147,000Institution0.35%3,060,540
133,539Institution0.32%2,780,282
101,919Institution0.25%2,121,954

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,248,433Institution3.00%31,198,341
917,123Institution2.21%22,918,904
1,031,667Institution2.48%21,479,307
309,536Institution0.74%7,735,305
334,361Institution0.80%6,961,396
252,573Institution0.61%6,311,799
273,710Institution0.66%5,698,642
170,497Institution0.41%4,260,720
135,039Institution0.32%3,374,625
102,914Institution0.25%2,191,039

FAQ

Who Owns Kiniksa Pharmaceuticals (KNSA)?
According to the latest TipRanks data, approximately 49.84% of the company's stock is held by institutional investors, 7.98% is held by insiders, and 18.96% is held by retail investors.
    What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 49.84% of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors.
      What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 18.96% of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors.
        Who owns the most shares of Kiniksa Pharmaceuticals (KNSA)?
        Peter Harwin owns the most shares of Kiniksa Pharmaceuticals (KNSA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis